STERIS plc (ste)
STE — Company Overview
STERIS plc (STE) is a large-cap company in the Healthcare sector, operating in Medical Devices.
| Ticker | STE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Exchange | NYQ |
| Market cap | $20.47B |
| Last price | $209.98 |
| Size category | Large Cap |
STE — Business Description
STERIS plc (STE) operates in Medical Devices within the broader Healthcare market. STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsou…
Official website: https://www.steris.com.
STE — Investment Thesis
The investment thesis for STERIS plc (STE) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.
- Revenue is expanding at roughly 7.3% year-over-year (public data).
- Trailing P/E of 25.51× sits in a moderate band relative to high-growth peers.
- Forward P/E (17.15×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 1.2% adds an income component to total return.
- Equity market capitalization is approximately $20.47B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
STE — Financial Health
Financial health for STERIS plc (STE) is summarized from publicly reported profitability, leverage, and cash-flow metrics.
Profit margin near 13.3% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $798.86M supports balance-sheet flexibility.
| Trailing P/E | 25.51× |
| Forward P/E | 17.15× |
| Price / Sales | 3.39× |
| Price / Book | 2.84× |
| Gross margin | 44.4% |
| Operating margin | 19.2% |
| Profit margin | 13.3% |
| Return on equity | 11.4% |
| Debt / Equity | 28.31 |
| Free cash flow | $798.86M |
STE — Growth Outlook
Growth outlook for STERIS plc (STE) depends on demand trends in Medical Devices and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 7.3% suggests steady but measured expansion.
- Earnings growth of 14.0% year-over-year supports improving profitability.
- Price is 22.1% below the 52-week high.
- Shares trade 7.6% above the 52-week low — limited rebound so far.
STE — Competitive Position
STERIS plc (STE) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Devices.
- Market capitalization of $20.47B places STE among large-cap peers.
- Gross margin near 44.4% may reflect pricing power or favorable mix.
STE — Strengths
Strengths for STERIS plc (STE) inferred from public financial metrics:
- Revenue growth of 7.3% year-over-year.
- Earnings growth of 14.0% year-over-year.
- Gross margin of 44.4% supports competitive unit economics.
- Positive free cash flow ($798.86M).
- Moderate leverage (debt/equity 28.31).
- Large Cap scale ($20.47B) may provide distribution and funding advantages.
STE — Weaknesses
Weaknesses and pressure points for STERIS plc (STE) based on available data:
Insufficient public data to assess this factor.
STE — Opportunities
- Trading 7.6% above the 52-week low — potential recovery if fundamentals stabilize.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
STE — Risks
- Standard market, regulatory, competitive, and execution risks apply to all public equities.
STE — Summary
STERIS plc (STE) is a large-cap Healthcare company focused on Medical Devices, listed on NYQ. Last price $209.98 with market cap $20.47B. Trailing P/E 25.51×. Revenue grew 7.3% year-over-year per public data. Notable strengths include revenue growth of 7.3% year-over-year. Public estimates and earnings snapshots for STERIS plc are on this site; ownership, live news, and deeper models remain in Vest Terminal.
Start Free — open STE in Vest Terminal
Access live data, filings, ownership, and analysis for STERIS plc.
STERIS plc FAQ
What does STERIS plc (STE) do?
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assuran…
What is STE's P/E ratio?
STERIS plc has a trailing P/E of 25.51× based on publicly available market data.
Does STE pay a dividend?
Indicated dividend yield: 1.2%. Confirm ex-dates and payout history in Vest Terminal.
What sector is STE in?
STERIS plc is classified in Healthcare (Medical Devices) on NYQ.
What is STE's market capitalization?
Approximate market cap: $20.47B.
What are the main risks for STE?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of STE?
Potential positives include revenue growth of 7.3% year-over-year, earnings growth of 14.0% year-over-year.
Where can I get analyst estimates for STE?
Public analyst price targets and consensus for STERIS plc are on the free /stocks/ste/estimates page. Deeper estimate history and models are available in Vest Terminal.